Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000491011 | SCV000580076 | uncertain significance | Hereditary cancer-predisposing syndrome | 2013-01-10 | criteria provided, single submitter | clinical testing | There is insufficient or conflicting evidence for classification of this alteration. |
Illumina Laboratory Services, |
RCV001097391 | SCV001253669 | likely benign | Familial adenomatous polyposis 2 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Sema4, |
RCV000491011 | SCV002532218 | likely benign | Hereditary cancer-predisposing syndrome | 2021-05-11 | criteria provided, single submitter | curation | |
Labcorp Genetics |
RCV001097391 | SCV002939391 | benign | Familial adenomatous polyposis 2 | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV000504244 | SCV000592670 | uncertain significance | not provided | no assertion criteria provided | clinical testing |